Advertisement

Canopy Growth Is Growing More Pot Than It Can Sell, MKM Says

Priya Nigam
·2-min read

While Canopy Growth Corp (NYSE: CGC) has announced strategic changes that could help lower its cost burden, the company is “sized for growth” that may not materialize in the medium-term, according to MKM Partners.

The Canopy Growth Analyst

Bill Kirk maintained a Neutral rating on Canopy Growth and reduced the price target from CA$21 ($15.56) to CA$19 ($14.08).

The Canopy Growth Thesis

Canopy Growth reported sequential deceleration in revenue and a wider EBITDA loss for the fiscal fourth quarter, while most peers announced sequential improvements, Kirk said in a Thursday note. (See his track record here.)

ADVERTISEMENT

Canopy Growth identified certain strategic and organizational changes, like facilities closures, market exits and layoffs, which may reduce its cost burden, the analyst said.

Yet the company is too large for the current environment and continues to cultivate much more than it can sell, he said.

Kirk further said that Canopy Growth may not make much progress on the adjusted EBITDA front in fiscal 2021, given low-priced and lower -margin value offerings being the primary growth opportunity.

“Upside in Canopy shares is more likely via legislative changes/excitement than operational improvement.”

CGC Price Action

Shares of Canopy Growth had declined a little over 1% to $16.35 at the time of publication Thursday.

Related Links

Aphria, Aurora Analyst Says Buy The Dip To Take Advantage Of Cannabis Stock Sell-Off

Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Latest Ratings for CGC

Feb 2020

Stifel Nicolaus

Maintains

Buy

Jan 2020

BMO Capital

Upgrades

Market Perform

Outperform

Nov 2019

Bank of America

Upgrades

Neutral

Buy

View More Analyst Ratings for CGC
View the Latest Analyst Ratings

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.